Dermira sweeps PhIII psoriasis studies for Cimzia as rivals threaten another entry
Dermira has wrapped the third and final psoriasis study of Cimzia, which the biotech says cleared the final hurdles in the lead up to …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
